Posaconazole combined with amphotericin B, an effective therapy for a murine disseminated infection caused by Rhizopus oryzae

Antimicrobial Agents and Chemotherapy

Volumn 52, Issue 10, 2008, Pages 3786-3788

  Rodríguez, M Mar ^a   Serena, Carolina ^a   Mariné, Marçal ^a   Pastor, F Javier ^a   Guarro, Josep ^a,b  

^a FACULTAT DE MEDICINA I CIÈNCIES DE LA SALUT   (Spain)

^b UNIVERSITAT ROVIRA I VIRGILI   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B DEOXYCHOLATE; CYCLOPHOSPHAMIDE; FLUOROURACIL; POSACONAZOLE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIFUNGAL ACTIVITY; ARTICLE; BRAIN; COLONY FORMING UNIT; CONTROLLED STUDY; DRUG EFFICACY; DRUG MEGADOSE; DRUG POTENTIATION; KIDNEY; LOW DRUG DOSE; MALE; MINIMUM INHIBITORY CONCENTRATION; MONOTHERAPY; MORTALITY; MOUSE; MUCORMYCOSIS; NONHUMAN; PRIORITY JOURNAL; RHIZOPUS ORYZAE; SINGLE DRUG DOSE; SURVIVAL TIME;

AMPHOTERICIN B; ANIMALS; ANTIFUNGAL AGENTS; COLONY COUNT, MICROBIAL; DISEASE MODELS, ANIMAL; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; HUMANS; MALE; MICE; MUCORMYCOSIS; RHIZOPUS; TRIAZOLES;

EID: 54049146733     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.00628-08     Document Type: Article

References (15)

1. Almyroudis, N. G., D. A. Sutton, A. W. Fothergill, M. G. Rinaldi, and S. Kusne. 2007. In vitro susceptibilities of 217 clinical isolates of zygomycetes to conventional and new antifungal agents. Antimicrob. Agents Chemother. 51:2587-2590.
2. Barchiesi, F., E. Spreghini, A. Santinelli, A. W. Fothergill, E. Pisa, D. Giannini, M. G. Rinaldi, and G. Scalise. 2007. Posaconazole prophylaxis in experimental systemic zygomycosis. Antimicrob. Agents Chemother. 51: 73-77.
3. Capilla, J., C. Serena, F. J. Pastor, M. Ortoneda, and J. Guarro. 2003. Efficacy of voriconazole in treatment of systemic scedosporiosis in neutropenic mice. Antimicrob. Agents Chemother. 47:3976-3978.
4. Dannaoui, E., J. F. G. M. Meis, D. Loebenberg, and P. E. Verweij. 2003. Activity of posaconazole in treatment of experimental disseminated zygomycosis. Antimicrob. Agents Chemother. 47:3647-3650.
5. Eliopoulos, G. M., and R. C. Moellering. 1991. Antimicrobial combinations, p. 432-492. In V. Lorian (ed.), Antibiotics in laboratory medicine, 3rd ed. Williams & Wilkins, Baltimore, MD.
6. Greenberg, R. N., K. Mullane, J. A. van Burik, I. Raad, M. J. Abzug, G. Anstead, R. Herbrecht, A. Langston, K. A. Marr, G. Schiller, M. Schuster, J. R. Wingard, C. E. Gonzalez, S. G. Revankar, G. Corcoran, R. J. Kryscio, and R. Hare. 2006. Posaconazole as salvage therapy for zygomycosis. Antimicrob. Agents Chemother. 50:126-133.
7. Johnson, M. D., C. MacDougall, L. Ostrosky-Zeichner, J. R. Perfect, and J. H. Rex. 2004. Combination antifungal therapy. Antimicrob. Agents Chemother. 48:693-715.
8. National Committee for Clinical Laboratory Standards. 2002. Reference method for broth dilution antifungal susceptibility testing of filamentous fungi. Approved standard M38-A. National Committee for Clinical Laboratory Standards, Wayne, PA.
9. Rickerts, V., J. Atta, S. Herrmann, V. Jacobi, E. Lambrecht, R. Bialek, and G. Just-Nübling. 2006. Successful treatment of disseminated mucormycosis with a combination of liposomal amphotericin B and posaconazole in a patient with acute myeloid leukaemia. Mycoses 49:27-30.
10. Roden, M. M., T. E. Zaoutis, W. L. Buchanan, T. A. Knudsen, T. A. Sarkisova, R. L. Schaufele, M. Sein, T. Sein, C. C. Chiou, J. H. Chu, D. P. Kontoyiannis, and J. Walsh. 2005. Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin. Infect. Dis. 41:634-653.
11. Rogers, T. R. 2008. Treatment of zygomycosis: current and new options. J. Antimicrob. Chemother. 61:35-39.
12. Spellberg, B., J. Edwards, Jr., and A. Ibrahim. 2005. Novel perspectives on mucormycosis: pathophysiology, presentation, and management. Clin. Microbiol. Rev. 18:556-559.
13. Sugar, A. M., and X. Liu. 2000. Combination antifungal therapy in treatment of murine pulmonary mucormycosis: roles of quinolones and azoles. Antimicrob. Agents Chemother. 44:2004-2006.
14. Sun, Q. N., A. W. Fothergill, D. I. McCarthy, M. G. Rinaldi, and J. R. Graybill. 2002. In vitro activities of posaconazole, itraconazole, voriconazole, amphotericin B, and fluconazole against 37 clinical isolates of zygomycetes. Antimicrob. Agents Chemother. 46:1581-1582.
15. van Burik, J., R. S. Hare, H. F. Solomon, M. L. Corrado, and D. P. Kontoyiannis. 2006. Posaconazole is effective as salvage therapy in zygomycosis: a retrospective summary of 91 cases. Clin. Infect. Dis. 42:61-65.